logo
Select company
Select metric
$ -19.71MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
20
Sector
50
Industry
66
History
65
$ 2.37Close
$ 1.9 - $ 3.9 52-Week Range
Ticker Information

Ticker

LSTA

Company Name

LISATA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LISATA THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LSTA - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 170K$ -19.89M$ -19.71M
3/31/2025$ 171K$ -20.27M$ -20.1M
12/31/2024$ 174K$ -20.78M$ -20.61M
9/30/2024$ 180K$ -21.54M$ -21.36M
6/30/2024$ 185K$ -21.87M$ -21.68M
3/31/2024$ 187K$ -23.18M$ -23M
12/31/2023$ 189K$ -23.17M$ -22.98M
9/30/2023$ 189K$ -23.8M$ -23.61M
6/30/2023$ 150K$ -55.92M$ -55.77M
3/31/2023$ 110K$ -56.19M$ -56.08M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LISATA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -18.49M.
  • Over the past 5 years, LISATA THERAPEUTICS INC's average EBITDA has been $ -29.82M.
  • The median EBITDA for LISATA THERAPEUTICS INC during this period was $ -23.32M
  • LISATA THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ -18.49M.
  • The lowest EBITDA recorded by LISATA THERAPEUTICS INC in the same timeframe $ -57.48M

LISATA THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.31MRLYB : RALLYBIO CORP $ -41.54MICU : SEASTAR MEDICAL HOLDING CORP $ -14.63MCLSD : CLEARSIDE BIOMEDICAL INC $ -26.67MIGC : IGC PHARMA INC $ -5.75MRANI : RANI THERAPEUTICS HOLDINGS INC $ -22.1MLEXX : LEXARIA BIOSCIENCE CORP $ -11.27MAPRE : APREA THERAPEUTICS INC $ -14.83MPLUR : PLURI INC $ -21.19MLYRA : LYRA THERAPEUTICS INC $ -38.37M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for LISATA THERAPEUTICS INC is calculated as follows: EBIT [ $ -18.55M ] + DepAmor [ $ 61K ]
(=) EBITDA [ $ -18.49M ]

LSTA - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -57.48M

Minimum

Sep 30, 2022

$ -18.49M

Maximum

Sep 30, 2020

$ -29.82M

Average

$ -23.32M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M